Clinical Trial Update: Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA

View source ↗

Summary

A clinical trial is evaluating urinary CXCL10 as a biomarker to improve detection of acute kidney allograft rejection in kidney transplant patients with low dd-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Allograft Rejection
• Kidney Transplant Rejection

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Kidney Transplant Rejection | Status: RECRUITING